Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Days Payable : 118.70 (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Days Payable?

Parnell Pharmaceuticals Holdings's average Accounts Payable for the six months ended in Dec. 2018 was $2.57 Mil. Parnell Pharmaceuticals Holdings's Cost of Goods Sold for the six months ended in Dec. 2018 was $7.90 Mil. Hence, Parnell Pharmaceuticals Holdings's Days Payable for the six months ended in Dec. 2018 was 59.35.

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's Days Payable or its related term are showing as below:

PARNF's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 89.33
* Ranked among companies with meaningful Days Payable only.

Parnell Pharmaceuticals Holdings's Days Payable declined from Dec. 2016 (199.60) to Dec. 2018 (118.70). It may suggest that Parnell Pharmaceuticals Holdings accelerated paying its suppliers.

Parnell Pharmaceuticals Holdings Days Payable Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Days Payable Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Days Payable

Get a 7-Day Free Trial

88.21

161.17

199.60

164.33

118.70

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Days Payable	Get a 7-Day Free Trial			124.44	161.17	199.60	164.33	118.70

Competitive Comparison of Parnell Pharmaceuticals Holdings's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Days Payable falls into.

Parnell Pharmaceuticals Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Parnell Pharmaceuticals Holdings's Days Payable for the fiscal year that ended in Dec. 2018 is calculated as

	Days Payable (A: Dec. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2017 )	+	Accounts Payable (A: Dec. 2018 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2018 )	*	Days in Period
=	( (2.404	+	2.736)	/	2 )	/	7.903	*	365
=	2.57					/	7.903	*	365
=	118.70

Parnell Pharmaceuticals Holdings's Days Payable for the quarter that ended in Dec. 2018 is calculated as:

	Days Payable (Q: Dec. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2017 )	+	Accounts Payable (Q: Dec. 2018 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2018 )	*	Days in Period
=	( (2.404	+	2.736)	/	2 )	/	7.903	*	365 / 2
=	2.57					/	7.903	*	365 / 2
=	59.35

Parnell Pharmaceuticals Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.